ML22034A628

From kanterella
Revision as of 18:46, 18 November 2024 by StriderTol (talk | contribs) (StriderTol Bot change)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Shine Technologies, LLC Application for Operating License Supplement 14, Revision to Final Safety Analysis Report, Chapter 14, Technical Specifications
ML22034A628
Person / Time
Site: SHINE Medical Technologies
Issue date: 01/26/2022
From:
SHINE Technologies, SHINE Health. Illuminated
To:
Office of Nuclear Reactor Regulation
Shared Package
ML22034A612 List:
References
2022-SMT-0007
Download: ML22034A628 (6)


Text

Chapter 14 - Technical Specifications Table of Contents

CHAPTER 14

TECHNICAL SPECIFICATIONS

TABLE OF CONTENTS

Section Tit le Page

14.1 TECHNICAL SPECIFICATIONS......................................................................... 14.1-1

14.2 REFERENCES

.................................................................................................... 14.2-1

SHINE Medical Technologies 14-i Rev. 0 Chapter 14 - Technical Specifications List of Tables

LIST OF TABLES

Number Tit le None

SHINE Medical Technologies 14-ii Rev. 0 Chapter 14 - Technical Specifications List of Figures

LIST OF FIGURES

Number Tit le None

SHINE Medical Technologies 14-iii Rev. 0 Chapter 14 - Technical Specifications Acronyms and Abbreviations

ACRONYMS AND ABBREVIATIONS

Acronym/Abbreviation Definition

ANS American Nuclear Society

ANSI American National Standards Institute

SHINE Medical Technologies 14-iv Rev. 0 Chapter 14 - Technical Specifications Technical Specifications

CHAPTER 14 - TECHNICAL SPECIFICATIONS

14.1 TECHNICAL SPECIFICATIONS

The SHINE technical specifications were developed following the format and content guidance of American National Standards Institute/American Nuclear Society (ANSI/ANS) 15.1-2007, The Development of Technical Specifications for Research Reactors (ANSI/ANS, 2007), and incorporating the applicable guidance of NUREG-1537, Parts 1 and 2 (USNRC, 1996a; USNRC, 1996b) and the Interim Staff Guidance Augmenting NUREG-1537, Parts 1 and 2 (USNRC, 2012a; USNRC, 2012b). Normal operation of the SHINE facility within the limits of the technical specifications will not result in offsite radiation exposure in excess of 10 CFR Part 20 guidelines.

Observance of these technical specifications limits the likelihood and consequences of malfunctions.

SHINE Medical Technologies 14.1-1 Rev. 0 Chapter 14 - Technical Specifications References

14.2 REFERENCES

ANSI/ANS, 2007. The Development of Technical Specifications for Research Reactors, American National Standards Institute, ANSI/ANS-15.1, 2007.

USNRC, 1996a. Guidelines for Preparing and Reviewing Applications for the Licensing of Non-Power Reactors: Format and Content, NUREG-1537, Part 1, U.S. Nuclear Regulatory Commission, February 1996.

USNRC, 1996b. Guidelines for Preparing and Reviewing Applications for the Licensing of Non-Power Reactors: Standard Review Plan and Acceptance Criteria, NUREG-1537, Part 2, U.S. Nuclear Regulatory Commission, February 1996.

USNRC, 2012a. Interim Staff Guidance Augmenting NUREG-1537, Part 1, Guidelines for Preparing and Reviewing Applications for the Licensing of Non-Power Reactors: Format and Content, for Licensing Radioisotope Production Facilities and Aqueous Homogeneous Reactors, Interim Staff Guidance Augmenting NUREG-1537, Part 1, U.S. Nuclear Regulatory Commission, October 27, 2012.

USNRC, 2012b. Interim Staff Guidance Augmenting NUREG-1537, Part 2, Guidelines for Preparing and Reviewing Applications for the Licensing of Non-Power Reactors: Standard Review Plan and Acceptance Criteria, for Licensing Radioisotope Production Facilities and Aqueous Homogeneous Reactors, Interim Staff Guidance Augmenting NUREG-1537, Part 2, U.S. Nuclear Regulatory Commission, October 27, 2012.

SHINE Medical Technologies 14.2-1 Rev. 0